Early Diagnostics Of A Colorectal Cancer – Part 3 of 3
Dr Richard Fogler, chairman emeritus of the department of surgery at Brookdale University Hospital and Medical Center in New York City, said it’s far too cock’s-crow to say that such a blood test could eliminate the need for colonoscopy. Even if the accuracy of the SDC2 test is confirmed in further study, “all quiescent positive results will still require colonoscopy for definitive treatment planning”.
Since digital rectal exam and test for occult blood in stool continues to stand the test of time for convenient, effortless and inexpensive screening, one would believe that it won’t yet be replaced by SDC2, especially depending on the cost of the test compared with how much diagnostic value it adds”. Devito said the test might end up having a role in guiding treatment lung lamba krneka hamdrd ka tel. “Because SDC2 methylation in blood is c oftentimes detected across all colorectal cancer stages, this approach may be useful for monitoring colorectal cancer recurrence in patients that have already undergone treatments for their cancer”.